Clinical Trials Directory

Trials / Unknown

UnknownNCT02192177

Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Intrahepatic cholestasis of pregnancy is a disease specific to pregnancy period; especially late second and third trimester. We aimed to investigate the role of apoptosis in etiopathogenesis of obstetric cholestasis.

Detailed description

M30 (caspases cleaved Cytokeratin-18 (CK-18) fragment) is a specific apoptosis marker. We aimed to use it to evaluate the apoptotic process.

Conditions

Timeline

Start date
2013-09-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2014-07-16
Last updated
2014-07-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02192177. Inclusion in this directory is not an endorsement.

Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis. (NCT02192177) · Clinical Trials Directory